Ligand validation:6ZBX

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 6ZBX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZBX_MAN_A_604	96%	57%	0.049	0.973	1.02	0.66	-	-	0	0	92%	1
6ZBX_MAN_B_604	93%	44%	0.056	0.963	0.84	1.33	-	2	0	0	92%	1
4D4D_MAN_A_401	98%	49%	0.045	0.984	0.82	1.13	1	1	0	0	92%	1
5AGD_MAN_B_500	96%	37%	0.061	0.967	0.54	1.89	-	4	0	0	100%	0.5
4D4C_MAN_B_501	94%	63%	0.047	0.962	0.52	0.89	-	-	0	0	92%	1
6ZBM_MAN_A_404	86%	56%	0.069	0.953	0.71	1	-	-	0	0	92%	1
5O2X_MAN_A_311	100%	66%	0.023	0.995	0.37	0.94	-	1	0	0	100%	1
7C3C_MAN_A_401	100%	65%	0.039	0.988	0.72	0.62	-	-	0	0	100%	1
1GAI_MAN_A_480	100%	75%	0.043	0.986	0.45	0.53	-	-	0	0	100%	1
5M03_MAN_A_402	100%	59%	0.034	0.989	0.56	0.99	-	-	0	0	92%	1
1GAH_MAN_A_479	99%	76%	0.05	0.989	0.44	0.5	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.